<DOC>
	<DOCNO>NCT00309868</DOCNO>
	<brief_summary>We hypothesize nesiritide favorable effect decrease heart filling pressure echocardiogram study .</brief_summary>
	<brief_title>Study Nesiritide Diastolic Heart Failure .</brief_title>
	<detailed_description>In previous study , patient systolic heart failure give nesiritide reduced heart filling pressure . The FDA approve nesiritide patient . Between one-third one-half patient heart failure diastolic heart failure . Few patient study receive nesiritide . A study need test nesiritide specific type heart failure . Patients undergo heart catheterization heart biopsy . Patients transfer intensive care unit monitoring . An echocardiogram obtain , follow infusion nesiritide 24 hour . At completion infusion , repeat echocardiogram obtain .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Elevated heart filling pressure . Ejection fraction &gt; 45 % . Blood pressure &gt; 90 . Physician feels patient need intravenous medication heart failure . Patients receive intravenous medication . Patients significant heart disease unstable . Patients kidney failure severe heart valve disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>heart catheterization</keyword>
	<keyword>echocardiogram</keyword>
	<keyword>nesiritide</keyword>
</DOC>